Cargando…

Substrate Peptidomimetic Inhibitors of P. falciparum Plasmepsin X with Potent Antimalarial Activity

Plasmepsin X (PMX) is an aspartyl protease that processes proteins essential for Plasmodium parasites to invade and egress from host erythrocytes during the symptomatic asexual stage of malaria. PMX substrates possess a conserved cleavage region denoted by the consensus motif, SFhE (h=hydrophobic am...

Descripción completa

Detalles Bibliográficos
Autores principales:	Richardson, Lachlan W., Ashton, Trent D., Dans, Madeline G., Nguyen, Nghi, Favuzza, Paola, Triglia, Tony, Hodder, Anthony N., Ngo, Anna, Jarman, Kate E., Cowman, Alan F., Sleebs, Brad E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804387/ https://www.ncbi.nlm.nih.gov/pubmed/35906744 http://dx.doi.org/10.1002/cmdc.202200306

Ejemplares similares

Macrocyclic Peptidomimetic Plasmepsin X Inhibitors with Potent In Vitro and In Vivo Antimalarial Activity
por: Kovada, Vadims, et al.
Publicado: (2023)

Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life Cycle
por: Favuzza, Paola, et al.
Publicado: (2020)

Peptidomimetic plasmepsin inhibitors with potent anti-malarial activity and selectivity against cathepsin D
por: Zogota, Rimants, et al.
Publicado: (2019)

Plasmepsin X activates the PCRCR complex of Plasmodium falciparum by processing PfRh5 for erythrocyte invasion
por: Triglia, Tony, et al.
Publicado: (2023)

Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4
por: Ashton, Trent D., et al.
Publicado: (2023)

7-N-Substituted-3-oxadiazole Quinolones with Potent Antimalarial Activity Target the Cytochrome bc(1) Complex
por: Nguyen, William, et al.
Publicado: (2023)

In Silico and In Vitro Antimalarial Screening and Validation Targeting Plasmodium falciparum Plasmepsin V
por: Ji, Xin, et al.
Publicado: (2022)

Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X Inhibitors and Preclinical Safety Assessment of UCB7362
por: Lowe, Martin A., et al.
Publicado: (2022)

Plasmodium falciparum ookinete expression of plasmepsin VII and plasmepsin X
por: Li, Fengwu, et al.
Publicado: (2016)

Inhibition of Plasmepsin V Activity Demonstrates Its Essential Role in Protein Export, PfEMP1 Display, and Survival of Malaria Parasites
por: Sleebs, Brad E., et al.
Publicado: (2014)

Synthesis of Plasmepsin II Inhibitors – Potential Antimalarial Agents
por: Mueller, Reto, et al.
Publicado: (2003)

Essentiality of Plasmodium falciparum plasmepsin V
por: Boonyalai, Nonlawat, et al.
Publicado: (2018)

Reticulocyte binding protein homologues are key adhesins during erythrocyte invasion by Plasmodium falciparum
por: Triglia, Tony, et al.
Publicado: (2009)

Computational insights for predicting the binding and selectivity of peptidomimetic plasmepsin IV inhibitors against cathepsin D
por: Martins, Lucas Sousa, et al.
Publicado: (2022)

Understanding the structural basis of substrate recognition by Plasmodium falciparum plasmepsin V to aid in the design of potent inhibitors
por: Bedi, Rajiv K., et al.
Publicado: (2016)

Plasmodium falciparum Plasmepsin 2 Duplications, West Africa
por: Inoue, Juliana, et al.
Publicado: (2018)

The Medicines for Malaria Venture Malaria Box contains inhibitors of protein secretion in Plasmodium falciparum blood stage parasites
por: Looker, Oliver, et al.
Publicado: (2022)

Overexpression of plasmepsin II and plasmepsin III does not directly cause reduction in Plasmodium falciparum sensitivity to artesunate, chloroquine and piperaquine
por: Loesbanluechai, Duangkamon, et al.
Publicado: (2018)

Hydroxyethylamine Based Phthalimides as New Class of Plasmepsin Hits: Design, Synthesis and Antimalarial Evaluation
por: Singh, Anil K., et al.
Publicado: (2015)

Trafficking of plasmepsin II to the food vacuole of the malaria parasite Plasmodium falciparum
por: Klemba, Michael, et al.
Publicado: (2004)

Development and application of a high-throughput screening assay for identification of small molecule inhibitors of the P. falciparum reticulocyte binding-like homologue 5 protein
por: Sleebs, Brad E., et al.
Publicado: (2020)

Assessment of Biological Role and Insight into Druggability of the Plasmodium falciparum Protease Plasmepsin V
por: Polino, Alexander J., et al.
Publicado: (2020)

Robenidine Analogues Are Potent Antimalarials in Drug-Resistant Plasmodium falciparum
por: Krollenbrock, Alina, et al.
Publicado: (2021)

Appraisal of Bioactive Compounds of Betel Fruit as Antimalarial Agents by Targeting Plasmepsin 1 and 2: A Computational Approach
por: Fatimawali,, et al.
Publicado: (2021)

The nepenthesin insert in the Plasmodium falciparum aspartic protease plasmepsin V is necessary for enzyme function
por: Polino, Alexander J., et al.
Publicado: (2022)

Maturation and substrate processing topography of the Plasmodium falciparum invasion/egress protease plasmepsin X
por: Mukherjee, Sumit, et al.
Publicado: (2022)

Plasmodium falciparum Merozoite Invasion Is Inhibited by Antibodies that Target the PfRh2a and b Binding Domains
por: Triglia, Tony, et al.
Publicado: (2011)

Bioprospection of Selected Plant Secondary Metabolites as Modulators of the Proteolytic Activity of Plasmodium falciparum Plasmepsin V
por: Sulyman, Abdulhakeem Olarewaju, et al.
Publicado: (2023)

Pyrazoleamide compounds are potent antimalarials that target Na(+) homeostasis in intraerythrocytic Plasmodium falciparum
por: Vaidya, Akhil B., et al.
Publicado: (2014)

Analysis of structure and function of the giant protein Pf332 in Plasmodium falciparum
por: Hodder, Anthony N, et al.
Publicado: (2008)

Plasmepsin-like Aspartyl Proteases in Babesia
por: Šnebergerová, Pavla, et al.
Publicado: (2021)

Plasmepsin II–III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum
por: Bopp, Selina, et al.
Publicado: (2018)

A Plasmodium falciparum genetic cross reveals the contributions of pfcrt and plasmepsin II/III to piperaquine drug resistance
por: Kane, John, et al.
Publicado: (2023)

Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum intracellular secretory pathway
por: LaMonte, Gregory M., et al.
Publicado: (2020)

Linear peptidomimetics as potent antagonists of Staphylococcus aureus agr quorum sensing
por: Karathanasi, Georgia, et al.
Publicado: (2018)

Structural and Functional Basis of Potent Inhibition of Leishmanial Leucine Aminopeptidase by Peptidomimetics
por: Bhat, Saleem Yousuf, et al.
Publicado: (2021)

Discovery of Potent Peptidomimetic Antagonists for Heterochromatin Protein 1 Family Proteins
por: Lamb, Kelsey N., et al.
Publicado: (2021)

Antimalarial Activity of 4-Metoxychalcones: Docking Studies as Falcipain/Plasmepsin Inhibitors, ADMET and Lipophilic Efficiency Analysis to Identify a Putative Oral Lead Candidate
por: de Oliveira, Michael Eder, et al.
Publicado: (2013)

A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue
por: Sonoiki, Ebere, et al.
Publicado: (2017)

The protein aggregation inhibitor YAT2150 has potent antimalarial activity in Plasmodium falciparum in vitro cultures
por: Bouzón-Arnáiz, Inés, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_esf5fbl7rrb3fekq6h5aqlpgdb